Acute and long-term clinical and angiographic outcome after S-Stent implantation: S-Stent multicenter safety and efficacy trial.

Acute and long-term clinical and angiographic outcome after S-Stent implantation: S-Stent multicenter safety and efficacy trial. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Acute and long-term clinical and angiographic outcome after S-Stent implantation: S-Stent multicenter safety and efficacy trial. Abstract Text:

Charles Chan,Yean-Leng Lim,Teguh Santoso,Damras Tresukosol,Yean-Teng Lim,Shinjo Sonoda,Peter Fitzgerald,Charles Chan,Yean-Leng Lim,Teguh Santoso,Damras Tresukosol,Yean-Teng Lim,Shinjo Sonoda,Peter Fitzgerald,Charles Chan,Yean-Leng Lim,Teguh Santoso,Damras Tresukosol,Yean-Teng Lim,Shinjo Sonoda,Peter Fitzgerald,

The purpose of this study is to demonstrate safety and effectiveness of the S-Stent in de novo coronary lesions treated with conventional percutaneous coronary balloon angioplasty. Between January 2000 and June 2001, 120 patients were prospectively enrolled at four study centers. Patients were treated with coronary stenting in a total of 137 lesions. Procedural success was achieved in 100% of 137 attempted lesions. Clinical success was 99.8%. In-hospital mortality was 0.8%; myocardial infarction occurred in 0.8% and stent thrombosis in 0.8%. After stent implantation, the minimal lumen diameter increased from 0.92 +/- 0.43 to 2.74 +/- 0.36 mm (P < 0.0001) and the percent diameter stenosis decreased from 68.0 +/- 16.2 to 4.5 +/- 12.0 (P < 0.0001). At 6-month follow-up, the percent diameter stenosis was 33.5 +/- 21.3 and the angiographic restenosis rate was 16.5%. Target lesion revascularization was required in 12 patients (10.1%). We conclude that the use of S-Stent for coronary intervention resulted in a high procedural success rate and low angiographic restenosis at 6 months after implantation. Catheter Cardiovasc Interv 2004;62:439-444. Copyright 2004 Wiley-Liss, Inc.

Acute and long-term clinical and angiographic outcome after S-Stent implantation: S-Stent multicenter safety and efficacy trial. Publishing Authors By Initials

C Chan,YL Lim,T Santoso,D Tresukosol,YT Lim,S Sonoda,P Fitzgerald,C Chan,YL Lim,T Santoso,D Tresukosol,YT Lim,S Sonoda,P Fitzgerald,C Chan,YL Lim,T Santoso,D Tresukosol,YT Lim,S Sonoda,P Fitzgerald,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Acute and long-term clinical and angiographic outcome after S-Stent implantation: S-Stent multicenter safety and efficacy trial. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Catheterization and cardiovascular interventions :

VOLUME: 62

Page Numbers: 439-44

Journal Abbreviation:

ISSN: 1522-1946

DAY: 26

MONTH: Aug

YEAR: 2004

Acute and long-term clinical and angiographic outcome after S-Stent implantation: S-Stent multicenter safety and efficacy trial. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100884139

Acute and long-term clinical and angiographic outcome after S-Stent implantation: S-Stent multicenter safety and efficacy trial. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Acute and long-term clinical and angiographic outcome after S-Stent implantation: S-Stent multicenter safety and efficacy trial. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Acute and long-term clinical and angiographic outcome after S-Stent implantation: S-Stent multicenter safety and efficacy trial.

AFFILIATION: Department of Cardiology, National Heart Center, Singapore.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Catheter Cardiovasc Interv

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Acute and long-term clinical and angiographic outcome after S-Stent implantation: S-Stent multicenter safety and efficacy trial Related Publications

• Acute and long-term clinical and angiographic outcome after S-Stent implantation: S-Stent multicenter safety and efficacy trial.
• Adverse drug reactions associated with first-line anti-tuberculosis drug regimens.
• Anterior cervical foramenotomy for cervical radiculopathy.
• COX-2 in play at the AHA and the FDA.
• Callous unemotional traits and autistic psychopathy.
• Circadian variation of blood pressure and the vascular response to asynchronous stress.
• Comparison of ram sperm interaction with bovine cervical mucus.
• Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti.
• Cyclooxygenase isoforms and atherosclerosis.
• Direct analysis of backbone-backbone hydrogen bond formation in protein folding transition states.
• H/D exchange- and mass spectrometry-based strategy for the thermodynamic analysis of protein-ligand binding.
• Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003.
• Is brain stimulation a form of psychosurgery?
• Lived fictions: moving from pharmacology to ethnography.
• Long-term consequences of early infant injury and trauma upon somatosensory processing.
• Markers in normal and cancer stem cells.
• Peripheral clocks and the regulation of cardiovascular and metabolic function.
• Pr22 skull base reconstruction with free flaps.
• Prostaglandins: modulators of inflammation and cardiovascular risk.
• Reflections on a rural surgical practice: the trip of a lifetime.
• Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock.
• Role of acetylcholine in neurotransmission of the carotid body.
• Simulating imaging with the scanning ion-conductance microscope.
• Spatial analysis of Mycobacterium bovis infection in white-tailed deer (Odocoileus virginianus) in Michigan, USA.
• Structural specializations emerging late in mouse lens fiber cell differentiation.
• Systemic RNAi in Caenorhabditis elegans.
• The overall benefits risks and costs of multiple medical interventions may be less favourable than the sum of the benefits risks and costs of those individual interventions.
• Toll-like receptor-dependent and -independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1.
• Treatment of keratin intermediate filaments with sulfur mustard analogs.
• Video as a tool for improving tracheal intubation tasks for emergency medical and trauma care.